4//SEC Filing
Garella Rahul 4
Accession 0001593034-20-000011
CIK 0001593034other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:39 PM ET
Size
17.3 KB
Accession
0001593034-20-000011
Insider Transaction Report
Form 4
Garella Rahul
EVP, Intl Pharmaceuticals
Transactions
- Tax Payment
Ordinary Shares
2020-02-21$6.07/sh−1,662$10,088→ 30,371 total - Exercise/Conversion
Stock Incentive Plan Performance Share Units
2020-02-25−10,614→ 46,752 total - Tax Payment
Ordinary Shares
2020-02-23$6.07/sh−165$1,002→ 30,559 total - Exercise/Conversion
Ordinary Shares
2020-02-25+9,726→ 40,285 total - Tax Payment
Ordinary Shares
2020-02-25$6.07/sh−4,569$27,734→ 35,716 total
Footnotes (10)
- [F1]Thirty-three and one-third percent (33 1/3%) of Mr. Garella's February 21, 2017 grant of restricted stock units (RSUs) vested on February 21, 2020.
- [F10]These shares represent stock withheld by Endo International plc to satisfy Mr. Garella's tax withholding obligations on shares acquired upon vesting of performance share units.
- [F2]These shares represent stock withheld by Endo International plc to satisfy Mr. Garella's tax withholding obligations on shares acquired upon vesting of RSUs.
- [F3]Represents the vesting price which is the closing share price on February 21, 2020.
- [F4]Twenty-five percent (25%) of Mr. Garella's February 23, 2016 grant of RSUs vested on February 23, 2020.
- [F5]Represents the vesting price which is the closing share price on February 21, 2020, the last trading day prior to vesting.
- [F6]On February 25, 2020, based on performance against target levels with respect to Mr. Garella's February 21, 2017 grant of performance share units, these awards were released and the performance share units were converted into 9,726 ordinary shares. Of this amount, 4,569 ordinary shares were withheld by Endo International plc to satisfy Mr. Garella's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Garella.
- [F7]Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over three successive one-year periods, each as determined by Endo International plc's Board of Directors at the end of such periods.
- [F8]These securities were granted to Mr. Garella in consideration of his services as a senior executive of Endo International plc.
- [F9]This represents the automatic conversion of performance share units granted to Mr. Garella on February 21, 2017 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement.
Issuer
Endo International plc
CIK 0001593034
Entity typeother
Related Parties
1- filerCIK 0001783785
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 4:39 PM ET
- Size
- 17.3 KB